|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ramalingam S and Belani C: Systemic
chemotherapy for advanced non-small cell lung cancer: recent
advances and future directions. Oncologist. 13(Suppl 1): s5–s13.
2008. View Article : Google Scholar
|
|
3
|
Chaffer CL and Weinberg RA: A perspective
on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee RC, Feinbaum RL and Ambros V: The C.
elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee Y, Kim M, Han J, et al: MicroRNA genes
are transcribed by RNA polymerase II. EMBO J. 23:4051–4060. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cai X, Hagedorn CH and Cullen BR: Human
microRNAs are processed from capped, polyadenylated transcripts
that can also function as mRNAs. RNA. 10:1957–1966. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Murchison EP and Hannon GJ: miRNAs on the
move: miRNA biogenesis and the RNAi machinery. Curr Opin Cell Biol.
16:223–229. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lund E and Dahlberg JE: Substrate
selectivity of exportin 5 and Dicer in the biogenesis of microRNAs.
Cold Spring Harb Symp Quant Biol. 71:59–66. 2006. View Article : Google Scholar
|
|
9
|
Bueno MJ, Pérez de Castro I and Malumbres
M: Control of cell proliferation pathways by microRNAs. Cell Cycle.
7:3143–3148. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Y and Lee CG: MicroRNA and cancer -
focus on apoptosis. J Cell Mol Med. 13:12–23. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen CZ, Li L, Lodish HF and Bartel DP:
microRNAs modulate hematopoietic lineage differentiation. Science.
303:83–86. 2004. View Article : Google Scholar
|
|
12
|
Wang D, Qiu C, Zhang H, Wang J, Cui Q and
Yin Y: Human microRNA oncogenes and tumor suppressors show
significantly different biological patterns: from functions to
targets. PLoS One. 5:e130672010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen CZ: microRNAs as oncogenes and tumor
suppressors. N Engl J Med. 353:1768–1771. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yanaihara N, Caplen N, Bowman E, et al:
Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tognini P and Pizzorusso T:
MicroRNA212/132 family: molecular transducer of neuronal function
and plasticity. Int J Biochem Cell Biol. 44:6–10. 2012. View Article : Google Scholar
|
|
16
|
Wanet A, Tacheny A, Arnould T and Renard
P: miR-212/132 expression and functions: within and beyond the
neuronal compartment. Nucleic Acids Res. 40:4742–4753. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang S, Hao J, Xie F, et al:
Downregulation of miR-132 by promoter methylation contributes to
pancreatic cancer development. Carcinogenesis. 32:1183–1189. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lu J, Getz G, Miska EA, et al: MicroRNA
expression profiles classify human cancers. Nature. 435:834–838.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yu SL, Chen HY, Chang GC, et al: MicroRNA
signature predicts survival and relapse in lung cancer. Cancer
Cell. 13:48–57. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Song Q, Xu Y, Yang C, et al: miR-483-5p
promotes invasion and metastasis of lung adenocarcinoma by
targeting RhoGDI1 and ALCAM. Cancer Res. 74:3031–3042. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yoo JK, Jung HY, Lee JM, et al: The novel
miR-9500 regulates the proliferation and migration of human lung
cancer cells by targeting Akt1. Cell Death Differ. 21:1150–1159.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shi Y, Liu C, Liu X, Tang DG and Wang J:
The microRNA miR-34a inhibits non-small cell lung cancer (NSCLC)
growth and the CD44hi stem-like NSCLC cells. PLoS One.
9:e900222014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP
and Wei WI: Mature miR-184 as potential oncogenic microRNA of
squamous cell carcinoma of Tongue. Clin Cancer Res. 14:2588–2592.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schetter AJ, Leung SY, Sohn JJ, et al:
MicroRNA expression profiles associated with prognosis and
therapeutic outcome in colon adenocarcinoma. JAMA. 299:425–436.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ogawa R, Ishiguro H, Kuwabara Y, et al:
Expression profiling of micro-RNAs in human esophageal squamous
cell carcinoma using RT-PCR. Med Mol Morphol. 42:102–109. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gougelet A, Pissaloux D, Besse A, et al:
Micro-RNA profiles in osteosarcoma as a predictive tool for
ifosfamide response. Int J Cancer. 129:680–690. 2011. View Article : Google Scholar
|
|
27
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Scapoli L, Palmieri A, Lo Muzio L, et al:
MicroRNA expression profiling of oral carcinoma identifies new
markers of tumor progression. Int J Immunopathol Pharmacol.
23:1229–1234. 2010.
|
|
29
|
Wada R, Akiyama Y, Hashimoto Y, Fukamachi
H and Yuasa Y: miR-212 is downregulated and suppresses
methyl-CpG-binding protein MeCP2 in human gastric cancer. Int J
Cancer. 127:1106–1114. 2010. View Article : Google Scholar
|
|
30
|
Incoronato M, Garofalo M, Urso L, et al:
miR-212 increases tumor necrosis factor-related apoptosis-inducing
ligand sensitivity in non-small cell lung cancer by targeting the
antiapoptotic protein PED. Cancer Res. 70:3638–3646. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hatakeyama H, Cheng H, Wirth P, et al:
Regulation of heparin-binding EGF-like growth factor by miR-212 and
acquired cetuximab-resistance in head and neck squamous cell
carcinoma. PLoS One. 5:e127022010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gartel AL and Radhakrishnan SK: Lost in
transcription: p21 repression, mechanisms and consequences. Cancer
Res. 65:3980–3985. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
You J, Li Y, Fang N, et al: MiR-132
suppresses the migration and invasion of lung cancer cells via
targeting the EMT regulator ZEB2. PLoS One. 9:e918272014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Molnár V, Érsek B, Wiener Z, et al:
MicroRNA-132 targets HB-EGF upon IgE-mediated activation in murine
and human mast cells. Cell Mol Life Sci. 69:793–808. 2012.
View Article : Google Scholar
|
|
35
|
Anand S, Majeti BK, Acevedo LM, et al:
MicroRNA-132-mediated loss of p120RasGAP activates the endothelium
to facilitate pathological angiogenesis. Nat Med. 16:909–914. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vo N, Klein ME, Varlamova O, et al: A
cAMP-response element binding protein-induced microRNA regulates
neuronal morphogenesis. Proc Natl Acad Sci USA. 102:16426–16431.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wayman GA, Davare M, Ando H, et al: An
activity-regulated microRNA controls dendritic plasticity by
downregulating p250GAP. Proc Natl Acad Sci USA. 105:9093–9098.
2008. View Article : Google Scholar
|
|
38
|
Park JK, Henry JC, Jiang J, et al: miR-132
and miR-212 are increased in pancreatic cancer and target the
retinoblastoma tumor suppressor. Biochem Biophys Res Commun.
406:518–523. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Huang Y, Lei Y, Zhang H, Hou L, Zhang M
and Dayton AI: MicroRNA regulation of STAT4 protein expression:
rapid and sensitive modulation of IL-12 signaling in human natural
killer cells. Blood. 118:6793–6802. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tang Y, Banan A, Forsyth CB, et al: Effect
of alcohol on miR-212 expression in intestinal epithelial cells and
its potential role in alcoholic liver disease. Alcohol Clin Exp
Res. 32:355–364. 2008. View Article : Google Scholar
|
|
41
|
Sonkoly E, Wei T, Janson PC, et al:
microRNAs: novel regulators involved in the pathogenesis of
psoriasis? PLoS One. 2:e6102007. View Article : Google Scholar : PubMed/NCBI
|
